Healthcare Sector

LQDA

Market Tracker

  • LQDA (Selected)

    Liquidia Corporation

LQDA Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

LQDA Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

LQDA Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

LQDA Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/17/2025 CALL $12.50 7,663 +99 +1.31%
07/18/2025 CALL $10.00 622 +51 +8.93%
04/17/2025 PUT $10.00 392 +30 +8.29%
01/15/2027 CALL $15.00 58 +25 +75.76%
01/16/2026 CALL $7.50 643 +20 +3.21%
04/17/2025 CALL $12.50 471 +12 +2.61%
01/17/2025 CALL $10.00 2,587 -2 -0.08%
01/16/2026 CALL $10.00 1,848 -7 -0.38%
01/17/2025 CALL $15.00 12,161 -10 -0.08%
01/17/2025 PUT $15.00 15 -19 -55.88%
12/20/2024 PUT $12.50 0 -27 -100.00%
01/17/2025 CALL $7.50 1,220 -78 -6.01%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

LQDA Major Holders

Name Pct Held Shares Total
SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF 2.76% 1.79M 13.78M
Vanguard Total Stock Market Index Fund 2.37% 1.53M 11.81M
iShares Russell 2000 ETF 1.63% 1.06M 8.14M
Vanguard Extended Market Index Fund 1.06% 683.23k 5.27M
Fidelity Small Cap Index Fund 0.61% 393.73k 3.04M
Invesco ETF Tr II-Invesco DWA Small Cap Momentum ETF 0.42% 273.91k 2.11M
Fidelity Extended Market Index Fund 0.39% 253.96k 1.96M
iShares Russell 2000 Growth ETF 0.35% 227.62k 1.75M
Russell Inv Co- Tax-Managed U.S. Mid & Small Cap Fund 0.28% 178.93k 1.38M
iShares Russell 2000 Value ETF 0.26% 169.92k 1.31M

LQDA News

  • United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

    10/07 10:00 am

    GlobeNewswire Inc.

    Read more
  • Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

    10/02 06:00 am

    GlobeNewswire Inc.

    Read more
  • U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    08/19 06:00 am

    GlobeNewswire Inc.

    Read more
  • Liquidia corp chief medical officer sells $18.4k in stock - Investing.com

    07/15 09:39 pm

    Investing.com

    Read more
  • Liquidia Corp executive sells shares worth over $19,000 - Investing.com

    07/15 06:47 pm

    Investing.com

    Read more
  • Liquidia Corp executive sells over $14k in company stock - Investing.com

    07/15 06:47 pm

    Investing.com

    Read more
  • Voip-pal director Kevin Williams sells shares worth $19,234 By Investing.com - Investing.com

    07/15 06:47 pm

    Investing.com

    Read more
  • Forecasting The Future: 5 Analyst Projections For Liquidia

    06/25 03:00 pm

    Benzinga

    Read more
  • Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)

    06/18 08:42 am

    GlobeNewswire Inc.

    Read more
  • 7 Analysts Have This To Say About Liquidia

    06/03 08:00 am

    Benzinga

    Read more
  • Liquidia Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

    05/15 08:01 am

    Benzinga

    Read more
  • MannKind Outperforms As Tyvaso DPI Captures Market Share

    05/15 01:22 am

    Seeking Alpha

    Read more
  • Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA)

    05/14 09:35 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

    05/13 05:43 pm

    GlobeNewswire Inc.

    Read more
  • Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates

    05/10 08:50 am

    Zacks Investment Research

    Read more
  • Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

    05/10 08:00 am

    GlobeNewswire Inc.

    Read more
  • Arvinas, Inc. (ARVN) Reports Q1 Loss, Lags Revenue Estimates

    05/07 08:15 am

    Zacks Investment Research

    Read more
  • Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know

    04/26 10:00 am

    Zacks Investment Research

    Read more
  • Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline

    04/25 10:02 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

    04/02 09:00 am

    GlobeNewswire Inc.

    Read more
  • The Analyst Landscape: 5 Takes On Liquidia

    04/01 02:00 pm

    Benzinga

    Read more
  • Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    03/27 01:06 pm

    Benzinga

    Read more
  • Unveiling 6 Analyst Insights On Liquidia

    03/13 05:00 pm

    Benzinga

    Read more
  • Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates

    03/13 07:10 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

    03/13 06:00 am

    GlobeNewswire Inc.

    Read more
  • Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates

    03/07 06:10 pm

    Zacks Investment Research

    Read more
  • Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline

    03/07 11:00 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

    03/06 07:30 am

    GlobeNewswire Inc.

    Read more
  • Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates

    02/29 09:40 am

    Zacks Investment Research

    Read more
  • Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates

    02/27 09:30 am

    Zacks Investment Research

    Read more
  • Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4

    02/22 06:15 pm

    Zacks Investment Research

    Read more
  • United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates

    02/22 01:22 pm

    Zacks Investment Research

    Read more
  • Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?

    02/19 06:54 am

    Zacks Investment Research

    Read more
  • This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate

    02/12 12:00 pm

    Benzinga

    Read more
  • Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress

    01/30 07:30 am

    GlobeNewswire Inc.

    Read more
  • Wall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 71.41%: Read This Before Placing a Bet

    01/29 10:55 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder

    01/25 07:00 am

    GlobeNewswire Inc.

    Read more
  • Liquidia Corporation Announces Updates to Operations Leadership

    01/19 07:30 am

    GlobeNewswire Inc.

    Read more
  • Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    01/17 02:12 pm

    Benzinga

    Read more
  • Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade

    01/09 07:21 pm

    Zacks Investment Research

    Read more
  • What Makes Liquidia Technologies, Inc. (LQDA) a Strong Momentum Stock: Buy Now?

    01/09 05:56 pm

    Zacks Investment Research

    Read more
  • Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims

    01/08 09:22 am

    GlobeNewswire Inc.

    Read more
  • Decoding 5 Analyst Evaluations For Liquidia

    01/05 09:00 am

    Benzinga

    Read more
  • Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD

    01/05 07:45 am

    GlobeNewswire Inc.

    Read more
  • Liquidia Corporation Announces $100 Million in New Financings

    01/04 10:10 am

    GlobeNewswire Inc.

    Read more
  • Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

    01/02 07:45 am

    GlobeNewswire Inc.

    Read more
  • B of A Securities Maintains Buy Rating for Liquidia: Here's What You Need To Know

    12/21 01:00 pm

    Benzinga

    Read more
  • U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)

    12/20 05:56 pm

    GlobeNewswire Inc.

    Read more
  • Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    12/20 02:16 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: